Top in endocrinology: Diabetes and COVID-19, hypothyroidism, postmenopausal osteoporosis
Results of a large study showed that 10% of patients with diabetes who were hospitalized with COVID-19 died and 20.3% required intubation within 7 days of admission. It was the top story story in endocrinology last week.
Another top story was about a study that showed hypothyroidism was more prevalent among adults who worked more hours per week.
Read these and more top stories in endocrinology below:
10% of people with diabetes, COVID-19 die within 7 days of hospital admission
The first large study assessing outcomes among people with diabetes hospitalized for COVID-19 shows that 10% of patients died and 20.3% required intubation for mechanical ventilation within 7 days of admission. Read more.
More hypothyroidism seen among adults with longer workweeks
Hypothyroidism was more than 2.5 times more prevalent among Korean adults who worked between 53 and 83 hours per week than those who worked between 36 and 42 hours per week. Read more.
Guideline highlights risk stratification in treating postmenopausal osteoporosis
A baseline fracture risk should guide the selection of initial osteoporosis therapy for postmenopausal women, and treatment should be continued for as long as the expected benefits outweigh the potential risks, according to an updated guideline from the American Association of Clinical Endocrinologists and the American College of Endocrinology. Read more.
Thousands of Medicare plans apply to Part D savings model capping insulin costs at $35
More than 1,750 standalone Medicare plans have applied to participate in an enhanced Part D Senior Savings Model that caps out-of-pocket insulin costs at $35 for a 30-day supply for the 2021 plan year, according to a press release from CMS. Read more.
Anti-Müllerian hormone receptor could help determine PCOS phenotype, severity
Levels of anti-Müllerian hormone and the soluble anti-Müllerian hormone receptor 2 could indicate the severity of glucose metabolism impairment associated with remaining ovarian function among women with polycystic ovary syndrome, according to findings from a cross-sectional study published in Clinical Endocrinology. Read more.